Covid-19 serology general clinical chemistry HbA1C IVD Diagnostic tests: PSA
Conditions
Interventions
None listed
Sponsors
Antoni van Leeuwenhoek Ziekenhuis
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Patients: 120x PSA requirest at blood collection facility 120x HbA1c request at blood collection facility Healthy volunteers: 120X Proven Covid-19 infection health care professional 120X Partner of NKI patient (without Cancer)
Exclusion criteria
Exclusion criteria: N.A.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary Objective: - To determine whether the finger prick blood collection system procedure can reliably replace venepuncture blood collection for the PSA, Covid-19 serology, HbA1c and routine clinical chemistry testing. Validation requirements: - Correlation coefficient (Spearmans) of finger prick with venipuncture serum is > 0,90. - Regression analysis: 95% CI of slope includes 1.00 - Less than 5% outliers (recovery 130%) | — |
Secondary
| Measure | Time frame |
|---|---|
| - Finger prick blood collection procedure performed by patients or healthy volunteers is feasible: > 80% of finger prick blood collection procedures performed results in a suitable sample for analysis. | — |
Countries
Netherlands
Outcome results
None listed